A member of the Rayner Executive Management Team, heading up the groups marketing, clinical and digital health teams globally.www.rayner.com/about-us/management-team/

* Responsible for the commercial launch of a novel IOL for cataract patients with AMD. Initially across EU5, then globally. * Total launch headcount 30 FTEs (4 direct, 26 indirect). Country Managers (4), Key Account Managers (25), MSL (1)* Developed and implemented the launch sales strategy, CRM platform using salesforce.com, the order management system, the Incentive Compensation Plan, the product and sales training program (nominated for a PF Award) and provided SME input to the marketing teams development of all sales and marketing collateral.This project was closed due to a lack of investor funding.

* Responsible for Field Sales, Field Service and Logistics across the UK & Nordics. * Total headcount 17 (8 direct, 9 indirect): Sales team (7), Field Service Engineering team (5), Logistics (5)* Delivered a turnaround in sales performance above corporate expectation: 78% revenue growth in year 1 and 33% revenue growth in year 2. * Awarded The Phoenix Award at the 2018 Global Sales Meeting for ‘an outstanding turnaround in performance’* Launched Daytona plus (UWF imaging device) and Monaco (OCT & UWF).

* Responsible for global (OUS) sales of the KAMRA Inlay, AcuTarget HD (Visiometrics) and the IC8 IOL.* Total headcount 15. Sales and clinical applications team members across EU and AP (Japan, Australia, Korea) plus field based Practice Development and Regional Marketing FTEs.* Direct management of distribution network in Europe (EU5), Middle East (KSA, UAE++) and Asia Pacific (Singapore, Korea, Japan)

* Responsible for the launch the KAMRA inlay, a VC backed new private pay surgical treatment for presbyopia. Initially in Europe, then into the Middle East and then Globally

Responsible for B+L’s global cataract equipment business, including category product line P&L responsibility, the indirect management of the regional marketing heads (EMEA, APAC, Canada, LA), and indirect management of the US equipment field sales team. Products Managed: Millennium, Stellaris and all related disposablesProducts Launched: US MICS Platform, Stellaris 2.0, MICS Phaco Pack Line, Stellaris EliteRevenue Responsibility $110M

Regional marketing leadership for B+L’s cataract and vitreoretinal business. Products Managed: Millennium, Stellaris and all related disposablesProducts Launched: MICS Platform, Stellaris Vision Enhancement System, Millennium Vitrectomy Enhancer, TSV PlatformRevenue Responsibility $65M

UK marketing leadership for 3M Health Care’s advanced wound care portfolio. Six Sigma Green Belt.Products Managed: Tegaderm, Tegasorb, Tegagen, and CobanProducts Launched: 3M Foam, Tegasorb Sacral

Sales responsibility for 3M’s Advanced Wound Care portfolio in two market sectors: Hospitals (direct sales) and Community (Rx sales) throughout central London from 2002 to mid-2003.109.1% over target for 2002Awarded 3M Sales Ambassador 2002122.3% over target for the 1st half of 2003Fast tracked to management after 18mths in sales